Hydroxychloroquine for treatment of COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials
Author:
Publisher
Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein
Subject
General Medicine
Reference39 articles.
1. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?;Devaux;Int J Antimicrob Agents,2020
2. Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19;Meo;Eur Rev Med Pharmacol Sci,2020
3. Connecting hydroxychloroquine in vitro antiviral activity to in vivo concentration for prediction of antiviral effect: a critical step in treating patients with coronavirus disease 2019;Fan;Clin Infect Dis,2020
4. ACTT-1 Study Group Members. Remdesivir for the treatment of Covid-19 - final report;Beigel;N Engl J Med,2020
5. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial;Hung;Lancet,2020
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comprehensive analysis of gastrointestinal side effects in COVID-19 patients undergoing combined pharmacological treatment with azithromycin and hydroxychloroquine: a systematic review and network meta-analysis;Critical Reviews in Toxicology;2024-06-11
2. Repurposing naproxen as a potential nucleocapsid antagonist of beta-coronaviruses: targeting a conserved protein in the search for a broad-spectrum treatment option;Journal of Biomolecular Structure and Dynamics;2024-02-26
3. Prevalence and predictors of self-medication to prevent or treat COVID-19 among undergraduate students in Southern Brazil;Anais da Academia Brasileira de Ciências;2024
4. Investigational medications in 9,638 hospitalized patients with severe COVID-19: lessons from the “fail-and-learn” strategy during the first two waves of the pandemic in 2020;Patient Safety in Surgery;2023-04-11
5. Investigational medications in 9,638 hospitalized patients with severe COVID-19: lessons from the “fail-and-learn” strategy during the first two waves of the pandemic in 2020;2023-02-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3